Altogen Labs

Altogen Labs is a biotechnology CRO company founded in 2008, headquartered in the United States. The company specializes in providing a range of services including GLP preclinical research, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services, in vivo siRNA delivery and biodistribution, and development of stable cell lines. Altogen Labs is recognized for its GLP compliant laboratory, catering to pharma, biotech companies, universities, and cancer research centers globally. Its service portfolio comprises pharmacology and toxicology assays, cell banking, generation of stable cell lines, RNAi gene silencing, and other in vitro services. In addition, Altogen Labs has ventured into bioremediation with an 'active bioremediation' process utilizing oil-degrading bacteria found at multiple oil spill sites in Texas. The technology has the potential to remediate large quantities of hydrocarbon-contaminated liquids or soil. Notably, the company filed a bioremediation patent application in 6/2012. However, there is no available information regarding the last investment or investors associated with Altogen Labs. The company operates within the Biotechnology and Health and Wellness industries. Altogen Labs' focus on preclinical testing services, safety, and efficacy studies positions it as a significant player in the biotech space. With a diversified portfolio of services and a foray into innovative bioremediation, Altogen Labs presents an intriguing opportunity for potential investors seeking exposure to the biotechnology sector.